Summer Stack – Retatrutide 10MG + Melanotan 2 10MG Research Bundle

The Summer Stack supplies Retatrutide (LY3437943) and Melanotan II as two separate 10mg lyophilized vials. The two act on unrelated receptor families: Retatrutide at the GLP-1, GIP, and glucagon receptors, and Melanotan II as a non-selective analogue of alpha-melanocyte-stimulating hormone at melanocortin receptors. For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.

Summer Stack: Retatrutide 10MG + Melanotan 2 10MG Research Bundle

This research bundle pairs Retatrutide, a novel triple-agonist metabolic peptide, with Melanotan 2, a synthetic analogue of alpha-melanocyte-stimulating hormone. Both peptides are subjects of active research interest with distinct and well-documented mechanisms of action.

Bundle Contents

• 1x Retatrutide 10MG lyophilized powder
• 1x Melanotan 2 10MG lyophilized powder
• Each vial independently tested for purity and identity

Research Context

Retatrutide (LY3437943) is a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. Published Phase 2 data has demonstrated dose-dependent metabolic effects in clinical research. Melanotan 2 is a cyclic lactam analogue of alpha-MSH with published research on melanocortin receptor activation in dermatological and metabolic research models. These compounds target distinct receptor systems and are frequently studied in parallel by researchers investigating metabolic pathways.

Certificates of Analysis

This is a bundle of separate vials, not a blend. Each compound is analysed on its own and carries its own batch certificate. One certificate never covers two different compounds unless they are supplied premixed in a single vial as a blend.

Third-party HPLC-UV testing by an independent third-party laboratory.

Storage

Store lyophilized powder at -20°C for long-term storage or 2-8°C for short-term. Protect from light and moisture.

Shipping

Same-day shipping on orders placed before 12 PM Pacific. Ships across Canada.

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.

For peer-reviewed research on this topic, visit PubMed.

Related Research Reading

Mechanistic background for each component is covered in Retatrutide triple receptor agonism and Melanotan II melanocortin receptor mechanisms. Third-party analytical documentation is published on the Certificates of Analysis page.